Search
Add filters:
Use filters to refine the search results.
Results 1-5 of 5 (Search time: 0.006 seconds).
- previous
- 1
- next
Item hits:
| Issue Date | Title | Author(s) |
|---|---|---|
| 30-Jul-2018 | Molecular therapies and precision medicine for hepatocellular carcinoma | Llovet i Bayer, Josep Maria; Montal, Robert; Sia, Daniela; Finn, Richard S. |
| 23-Jan-2017 | Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity | Moeini, Agrin; Sia, Daniela; Zhang, Zhongyang; Campreciós Figueras, Genís; Stueck, Ashley; Dong, Hui; Montal, Robert; Torrens, Laura; Martínez Quetglas, Iris; Fiel, Maria Isabel; Hao, Ke; Villanueva, Augusto; Thung, Swan N.; Schwartz, Myron; Llovet i Bayer, Josep Maria |
| 25-Jan-2017 | Objective response by mRECIST as a predictor and potential surrogate end point of overall survival in advanced HCC | Lencioni, Riccardo; Montal, Robert; Torre, Ferran; Park, Joong-Won; Decaens, Thomas; Raoul, Jean-Luc; Kudo, Masatoshi; Chang, Charissa Y.; Ríos, José; Boige, Valerie; Assenat, Eric; Kang, Yoon-Koo; Lim, Ho-Yeong; Walters, Ian; Llovet i Bayer, Josep Maria |
| 9-Jul-2019 | Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials | Montal, Robert; Andreu Oller, Carmen; Bassaganyas, Laia; Esteban Fabró, Roger; Moran, Sebastian; Montironi, Carla; Moeini, Agrin; Pinyol, Roser; Peix, Judit; Cabellos, Laia; Villanueva, Augusto; Sia, Daniela; Mazzaferro, Vincenzo; Esteller, Manel; Llovet i Bayer, Josep Maria |
| 31-Mar-2019 | Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival | Llovet i Bayer, Josep Maria; Montal, Robert; Villanueva, Augusto |